Business Segments · Total Assets
Diabetes Group — Total Assets
Medtronic Diabetes Group — Total Assets increased by 1.0% to $4.31B in Q1 2026 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ2 2018
Last reportedQ1 2026
Rolls up toTotal Assets
How to read this metric
An increase suggests capital expansion or growth in working capital, while a decrease may indicate asset divestitures or improved asset turnover.
Detailed definition
This represents the total value of all assets, including inventory, accounts receivable, property, plant, and equipment,...
Peer comparison
Standard balance sheet metric for business segments.
Metric ID:
mdt_segment_diabetes_total_assetsHistorical Data
8 periods
| Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $3.67B | $3.80B | $3.93B | $4.00B | $4.14B | $4.21B | $4.27B | $4.31B |
| QoQ Change | — | +3.4% | +3.5% | +1.7% | +3.5% | +1.8% | +1.5% | +1.0% |
| YoY Change | — | +3.4% | +3.5% | +1.7% | +3.5% | — | — | — |
Range$3.67B – $4.31B
CAGR+9.6%
Avg YoY Growth+3.0%
Median YoY Growth+3.5%
Current Streak7+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes group — total assets?
- Medtronic (MDT) reported diabetes group — total assets of $4.31B in Q1 2026.
- What does diabetes group — total assets mean?
- The total value of all resources and assets owned by the diabetes business segment.